HIV Pre-Exposure Prophylaxis (PrEP) Choices

This session will discuss the importance of having a variety of PrEP choices and provide an overview of PrEP options available in the United States. The session will review injectable PrEP options, including twice-yearly subcutaneous lenacapavir and every-two-month intramuscular cabotegravir, as well as daily oral PrEP options, including F/TAF and F/TDF.

Speakers:

David L. Bell, MD, MPH
Medical Director, The Lawrenceville School

David Malebranche, MD, MPH
Gilead Sciences

Moderators:

Gina Brown, MD
Gilead Sciences

Carolina Vargas, PharmD
Gilead Sciences

This event is supported by Gilead

Disclaimer: American College Health Association does not endorse any company, product, or service presented in industry-sponsored webinars. Presentation content is not part of American College Health Association’s accredited education programming. Presentation content may include product promotion.

Related Links:

ACHA Guidelines: HIV Pre-Exposure Prophylaxis

Sexual Health Services Survey

Access to Sexual and Reproductive Health Care Services Statement

Sexual & Reproductive Health

Promoting Reproductive Health Care Access on Campus: Implementation Toolkit